Citigroup’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,912
Closed -$3K 5765
2021
Q2
$3K Hold
1,912
﹤0.01% 5269
2021
Q1
$4K Hold
1,912
﹤0.01% 5313
2020
Q4
$4K Hold
1,912
﹤0.01% 5048
2020
Q3
$5K Hold
1,912
﹤0.01% 4716
2020
Q2
$8K Hold
1,912
﹤0.01% 4730
2020
Q1
$1K Hold
1,912
﹤0.01% 5045
2019
Q4
$2K Hold
1,912
﹤0.01% 5020
2019
Q3
$1K Sell
1,912
-127
-6% -$66 ﹤0.01% 5065
2019
Q2
$1K Sell
2,039
-1
-0% ﹤0.01% 5074
2019
Q1
$6K Hold
2,040
﹤0.01% 4871
2018
Q4
$4K Hold
2,040
﹤0.01% 4825
2018
Q3
$9K Hold
2,040
﹤0.01% 4756
2018
Q2
$9K Hold
2,040
﹤0.01% 4658
2018
Q1
$15K Buy
2,040
+1,990
+3,980% +$14.6K ﹤0.01% 4352
2017
Q4
$0 Hold
50
﹤0.01% 5076
2017
Q3
$0 Hold
50
﹤0.01% 4990
2017
Q2
$1K Hold
50
﹤0.01% 4823
2017
Q1
$1K Hold
50
﹤0.01% 4770
2016
Q4
$1K Hold
50
﹤0.01% 4827
2016
Q3
$1K Hold
50
﹤0.01% 4858
2016
Q2
$1K Sell
50
-6,378
-99% -$128K ﹤0.01% 4908
2016
Q1
$122K Buy
6,428
+4,107
+177% +$77.9K ﹤0.01% 3831
2015
Q4
$61K Buy
2,321
+2,000
+623% +$52.6K ﹤0.01% 3937
2015
Q3
$14K Buy
321
+7
+2% +$305 ﹤0.01% 4259
2015
Q2
$10K Sell
314
-147
-32% -$4.68K ﹤0.01% 4610
2015
Q1
$15K Sell
461
-1,888
-80% -$61.4K ﹤0.01% 4568
2014
Q4
$89K Buy
2,349
+1,697
+260% +$64.3K ﹤0.01% 3740
2014
Q3
$18K Sell
652
-107
-14% -$2.95K ﹤0.01% 4334
2014
Q2
$22K Sell
759
-1,049
-58% -$30.4K ﹤0.01% 4147
2014
Q1
$67K Sell
1,808
-2,192
-55% -$81.2K ﹤0.01% 3787
2013
Q4
$166K Buy
4,000
+2,884
+258% +$120K ﹤0.01% 3299
2013
Q3
$60K Sell
1,116
-294
-21% -$15.8K ﹤0.01% 3545
2013
Q2
$75K Buy
+1,410
New +$75K ﹤0.01% 3503